BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Du Z, Liu X, Wei X, Luo H, Li P, Shi M, Guo B, Cui Y, Su Z, Zeng J, Si A, Cao P, Zhou G. Quantitative proteomics identifies a plasma multi-protein model for detection of hepatocellular carcinoma. Sci Rep 2020;10:15552. [PMID: 32968147 DOI: 10.1038/s41598-020-72510-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhao X, Chai W, Wang T, Chen X, Zhang L, Li F, Liu R. Identification of the prognostic, diagnostic, and biological significance of the miR-148a-3p/cathepsin A axis in hepatocellular carcinoma. J Biochem Mol Toxicol 2022;:e23208. [PMID: 36065643 DOI: 10.1002/jbt.23208] [Reference Citation Analysis]
2 Kim JY, Kim J, Lim Y, Gwak G, Yeo I, Kim Y, Lee J, Shin D, Lee J, Kim Y. Proteome Multimarker Panel for the Early Detection of Hepatocellular Carcinoma: Multicenter Derivation, Validation, and Comparison. ACS Omega. [DOI: 10.1021/acsomega.2c02926] [Reference Citation Analysis]
3 Gao R, Yan J, Li P, Chen L. Detecting the critical states during disease development based on temporal network flow entropy. Brief Bioinform 2022:bbac164. [PMID: 35580862 DOI: 10.1093/bib/bbac164] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
4 Shao D, Huang L, Wang Y, Cui X, Li Y, Wang Y, Ma Q, Du W, Cui J. HBFP: a new repository for human body fluid proteome. Database (Oxford) 2021;2021:baab065. [PMID: 34642750 DOI: 10.1093/database/baab065] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
5 Büküm N, Novotná E, Morell A, Želazková J, Laštovičková L, Čermáková L, Portillo R, Solich P, Wsól V. Inhibition of AKR1B10-mediated metabolism of daunorubicin as a novel off-target effect for the Bcr-Abl tyrosine kinase inhibitor dasatinib. Biochem Pharmacol 2021;192:114710. [PMID: 34339712 DOI: 10.1016/j.bcp.2021.114710] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Wang H, Xu F, Yang F, Lv L, Jiang Y. Prognostic significance and oncogene function of cathepsin A in hepatocellular carcinoma. Sci Rep 2021;11:14611. [PMID: 34272452 DOI: 10.1038/s41598-021-93998-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Ruiz-Blázquez P, Pistorio V, Fernández-Fernández M, Moles A. The multifaceted role of cathepsins in liver disease. J Hepatol 2021:S0168-8278(21)01880-8. [PMID: 34242696 DOI: 10.1016/j.jhep.2021.06.031] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Moldogazieva NT, Mokhosoev IM, Zavadskiy SP, Terentiev AA. Proteomic Profiling and Artificial Intelligence for Hepatocellular Carcinoma Translational Medicine. Biomedicines 2021;9:159. [PMID: 33562077 DOI: 10.3390/biomedicines9020159] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 An PP, Feng LN, Zhang XX, Jin QL. Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis. Medicine (Baltimore) 2020;99:e23659. [PMID: 33327352 DOI: 10.1097/MD.0000000000023659] [Cited by in F6Publishing: 1] [Reference Citation Analysis]